✦ LIBER ✦

Quality of life in young patients with chronic myelocytic leukaemia during intensive treatment including interferon

✍ Scribed by Ann Marie Stalfelt; Olle Zettervall

Book ID: 114119123
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 926 KB
Volume: 21
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(97)00026-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life in patients with chronic

Quality of life in patients with chronic hepatitis C (HCV) during high dose induction interferon (IFN) treatment

✍ Cha, JW; Layden, TJ; Lam, NP 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Cytotoxic and noncytotoxic mechanisms in

Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon α

✍ Graham Pawelec; Markus Reutter; Martin Owsianowsky; Arnika Rehbein; Friedrich W. 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 879 KB

Dynamic change of T315I BCR-ABL kinase d

Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors

✍ Wan-Seok Kim; Dongho Kim; Dong-Wook Kim; Il-Young Kweon; Soo-Hyun Kim; Hyun-Gyun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

## Abstract We analysed the dynamic change of imatinib‐resistant mutations in BCR‐ABL kinase domain focusing on T315I mutation during dasatinib or nilotinib therapy. Fifty‐five imatinib‐resistant chronic myeloid leukaemia patients (32 patients with imatinib‐resistant mutations and 23 patients witho